SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
SOPHiA GENETICS (SOPH) CFO and COO to speak at Barclays Global Healthcare Conference on March 13, 2024. Webcast available on Investor Relations website.
03/07/2024 - 12:07 PM
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024, at 2:35 p.m. EDT.
The fireside chat will be webcast live on the SOPHiA GENETICS Investor Relations website . Additionally, a replay will be available on the website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-native platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products, and services are currently used by a broad network of hospital, laboratory, and biopharma institutions globally. For more information, visit SOPHiAGENETICS.COM , or connect on X , LinkedIn , Facebook , and Instagram . Where others see data, we see answers.
Investor Contact
Media Contact
When will SOPHiA GENETICS CFO and COO participate in the fireside chat at Barclays Global Healthcare Conference?
SOPHiA GENETICS CFO and COO, Ross Muken, will participate in the fireside chat on Wednesday, March 13, 2024, at 2:35 p.m. EDT.
Where can I watch the webcast of the fireside chat?
The webcast of the fireside chat will be available live on the SOPHiA GENETICS Investor Relations website.
Will there be a replay of the fireside chat available?
Yes, a replay of the fireside chat will be available on the SOPHiA GENETICS Investor Relations website after its completion.
SOPH Rankings
#276 Ranked by Stock Gains
SOPH Stock Data
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
About SOPH
sophia genetics, world's largest clinical genomics community, brings together expertise in genetics, bioinformatics, machine learning and genomic privacy. based in switzerland, we are known for our high medical standards and swiss precision. sophia genetics offers health professionals who perform clinical genetic testing unparalleled bioinformatics analysis, quality assurance and secure banking of patient dna sequence data generated by ngs. the company helps clinical laboratories to reduce costs, overcome complexity, significantly improve the turnaround time for routine diagnosis and meet quality requirements related to the use of ngs in the clinic. our solution, the sophia ddm™ platform allows hospitals to better and faster diagnose patients using cutting edge ngs analytics algorithms and through knowledge sharing within the largest clinical genomics community in the world (+100 hospitals). the name « sophia » means wisdom in greek and it is the definition of our excellence based
